DARIOLO, R. Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia. Swiss Medical Weekly, [S. l.], v. 138, n. 2930, p. 420–426, 2008. DOI: 10.4414/smw.2008.12120. Disponível em: https://smw.ch/index.php/smw/article/view/876. Acesso em: 17 sep. 2024.